Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide mapping of Xap5 and Nono binding sites by CUT&Tag in NIH/3T3 cells

ABSTRACT: This study maps the genome-wide binding sites of the proteins Xap5 and Nono in murine NIH/3T3 cells using CUT&Tag (Cleavage Under Targets and Tagmentation) sequencing. By employing antibodies specific to Xap5 and Nono, we profiled their protein-DNA interactions. The results identify numerous common genomic targets, highlighting a significant overlap in the DNA-binding profiles of these two proteins.

ORGANISM(S): Mus musculus

PROVIDER: GSE304980 | GEO | 2025/11/15

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptional profiling of Xap5, Nono, and Sox5 knockout mouse fibroblasts during primary ciliogenesis

Project description:The formation of primary cilia (ciliogenesis) is a fundamental process in mammalian development, governed by precise transcriptional programs. While the Rfx and Foxj1 transcription factors are known master regulators, the full scope of this control, particularly for primary cilia, is not completely understood. This study aims to define the transcriptional network downstream of the ancient, evolutionarily conserved factor Xap5, which we identified as a novel master regulator of primary ciliogenesis. To achieve this, we performed transcriptome analysis (RNA-seq) on wild-type (WT) NIH/3T3 mouse fibroblasts and derived knockout (KO) cell lines for Xap5, its interacting cofactor Nono, and a key downstream effector, Sox5. Cells were profiled following 24 hours of serum starvation, a condition that induces primary cilia formation and revealed a significant cilia elongation defect in all three knockout lines. Overall, this dataset provides a comprehensive resource for identifying the common and unique gene expression programs regulated by the Xap5-Nono-Sox5 transcriptional cascade, an Rfx-independent pathway essential for building the primary cilium.

2025-11-15 | GSE305355 | GEO

NIH 3T3: Ctrl vs Reo

Project description:Transcriptional profiling of NIH 3T3 comparing WT, RIG-I KD with and without reovirus infection

2020-10-07 | GSE127850 | GEO

NIH 3T3: Ctrl vs Reo

Project description:NIH 3T3: Ctrl vs Reo

| PRJNA525645 | ENA

Immediate Early Response 2 (Ier2) overexpression effect in NIH 3T3 cells

Project description:Analysis of Immediate Early Response 2 (Ier2)-inducible NIH 3T3 cells after Ier2 induction with RheoSwitch ligand RSL-1. Results provide insight into the function of Ier2 in NIH 3T3 mouse embryonal fibroblasts. Immediate early genes, including Ier2, are rapidly induced in quiescent cells by proliferation and migration-inducing stimuli. Microarray gene expression profiling was performed to identify differentially expressed genes following overexpression of Ier2 in NIH 3T3-Ier2 inducible cells after 24 hour induction of Ier2.

2021-10-07 | GSE181200 | GEO

dynamic SILAC NIH/3T3 treated with DMSO/CHX

Project description:NIH/3T3 cells were cultured at least 2 weeks in light medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (light) L-Lysine-2HCl (0.666 mM), (light) L-Arginine-HCl (0.399 mM)44, and L-Proline (200 mg/L). Before switching from light to heavy medium, cells were treated with 0.05 µg/mL CHX or equivalent dilution of DMSO in 6-well plates. At timepoint 0 h, we replaced light medium with pre-warmed heavy medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (heavy) 13C6 15N2 L-Lysine-2HCl (0.666 mM), (heavy) 13C6 15N4 L-Arginine-HCl (0.399 mM), and L-Proline (200 mg/L) for NIH/3T3.

2025-10-07 | PXD061384 | Pride

RNA-seq of NIH 3T3 and HepG2 cells after arsenite treatment

Project description:Expression profiling of HepG2 human liver carcinoma cells and NIH 3T3 mouse fibroblasts after arsite treatment for 24h. RNA-seq data comprise 4 groups: NIH 3T3 mouse fibroblasts control and arsite treatment, and HepG2 human liver carcinoma cells control and arsenite treatment. Jena Centre for Systems Biology of Ageing - JenAge (www.jenage.de)

2021-10-19 | GSE117815 | GEO

RNA-Seq of NIH-3T3 cells treated with CMA modulators

Project description:Transcriptomics of NIH-3T3 cells treated with CMA activators to evaluate gene expression changes

2022-06-06 | GSE194292 | GEO

Genome wide mapping of LSD1 binding sites in NIH/3T3

Project description:We provide the binding sites of LSD1 in NIH/3T3 cells mapped via ChIP-seq

2021-03-09 | GSE158441 | GEO

ETV6-NTRK3 fusion oncoprotein transduces NIH 3T3 cells

Project description:We report a mouse model that recapitulates expression of the ETV6-NTRK3 (EN) fusion oncoprotein, the product of the t(12;15)(p13;q25) translocation characteristic of human secretory breast carcinoma. Activation of EN expression in mammary tissues by Whey acidic protein (Wap) promoter-driven Cre leads to fully penetrant, multifocal malignant breast cancer with short latency. We provide genetic evidence that committed bipotent or CD61+ luminal alveolar progenitors, are targets of tumorigenesis. Furthermore, EN transforms these otherwise transient progenitors through activation of the AP1 complex. To study the initial effects of ETV6-NTRK3 (EN) mediated transformation, we retrovirally transduced NIH 3T3 cells and generated microarray expression profiling data of EN transduced 3T3 cells as well as control 3T3 cells. Using gene set enrichment analysis (GSEA), we identified a signature involving the AP1 transcriptional complex in EN transduced 3T3 cells. Keywords: genetic modification, cell type comparison

2007-12-14 | GSE9354 | GEO

Alterations of mRNAs in NIH/3T3 cells overexpressing BPV-13 E6

Project description:To find out differentially expressed mRNAs in NIH/3T3 cells overexpressing BPV-13 E6

2019-04-11 | GSE129593 | GEO